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jo u rn al ho m epag e: ww w.els evier . c om / lo cat e/ jds rBone loss in the maxillo-facial region is a major health care
concern. Maintaining the integrity of the bone structure
around the teeth or dental implants is crucial for preserving
oral function. Alveolar cleft repairs and maxillary defect
reconstruction after tumor surgeries are also challenging
requirements, as they need to be designed to meet specific
needs and demands for optimizing functional and cosmetic
outcomes. Autologous bone grafts have long been considered
the first choice for the repair of bone defects. This is a
standard treatment widely used for maxillo-facial skeletal
defects and deformities. However, the volume of the bone
graft harvest is restricted because of additional surgery and
donor site functional impairment. Bone tissues of allogeneic,
xenogeneic, or synthetic substitutes occasionally have lim-
itations of insufficient bone graft volume as well as risks of
immune rejection or contagious diseases. Recently, bone
tissue regeneration has been progressively achieved by the
application of tissue engineering, in which cells and growth
factors are combined with biocompatible scaffolds, providing
a promising approach for improved clinical application.
Therefore, selection of highly osteogenic cells is very impor-
tant to achieve effective treatment.
In this issue, Dr. Yamachika and Dr. Iida review the avail-
able evidence on the use of mesenchymal stem cells (MSCs)
for bone regeneration (page 35) [1]. They summarize the
immunophenotype of the MSCs reported in the literature and
provide results of their mice experiments. The sources of
adult MSCs and their suitability for bone regeneration appli-
cations are discussed in this review and a newly developed
approach using mice compact bone-derived MSCs is intro-
duced. They describe the use of serum-free medium for ex
vivo isolation and expansion of MSCs. Tumor formation by
MSCs is also discussed. This review greatly helps scientists to
comprehend the current progress and advantages of using
mesenchymal cells, and the limitations of animal models for
conducting bone tissue engineering research.
Significant research efforts have been undertaken in the
last decade to develop specific cell-based therapies. The
review by Arvidson et al. [2] highlights the research areas
of central importance in orthopedic and maxillofacial bone
tissue repair, including normal fracture healing, biomaterial
scaffolds for tissue engineering, and mesenchymal and fetal1882-7616/$ — see front matter # 2013 Published by Elsevier Ltd on be
http://dx.doi.org/10.1016/j.jdsr.2012.12.001stem cells. In this detailed review, the basic science and
recent advances related to MSCs and osteogenesis are dis-
cussed [2]. Multipotent MSCs hold great promise for skeletal
regenerative strategies. However, clinical translation of the
therapies has not been firmly established [3]. Steinert et al.,
in their review on MSCs, describe that, relatively, only a few
cell-based approaches have been applied at the clinical
level, and until date, none of these treatments has become
a ‘‘standard-of-care’’ treatment for an orthopedic disease.
They have discussed the multifaceted reasons for the current
status, from the medical, research, and regulatory perspec-
tives [3].The most recent strategy for bone tissue engineer-
ing is the use of induced pluripotent stem cells (iPSCs) [4].
iPSCs application was investigated in periodontal tissue
regeneration including alveolar bone formation [5].
Khojaseh and coworkers have reviewed studies published
in English language that applied MSCs as a part of the treat-
ment protocol for the reconstruction of bone defects in rat,
rabbit, dog, and human models [6]. Sources of stem cells,
experimental animals and subjects, sites and sizes of defects,
carriers and constructs, use of additional growth factors,
parameters measured, and methods of data collection vary
across studies. The choice of a well-validated model for bone
tissue regeneration engineering research remains a difficult
task. Additional research is the need of the hour for deter-
mining safer and efficient bone tissue engineering strategies
for potential clinical applications.
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